dr. brufsky on the colet trial for triple-negative breast cancer
Published 7 years ago • 221 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
1:22
dr. brufsky on cobimetinib plus paclitaxel in tnbc
-
1:31
dr. brufsky discusses the tnacity trial
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
1:06
dr. brufsky on challenges in breast cancer
-
1:30
dr. brufsky on genomic assays for breast cancer
-
7:06
tnt study in triple negative breast cancer
-
0:35
dr. brufsky discusses bevacizumab benefits in tnbc
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
1:41
dr. brufsky discusses the tnacity trial
-
0:30
dr. brufsky on adjuvant bisphosphonates for patients with breast cancer
-
1:16
dr. brufsky advises doctors on bevacizumab for breast cancer
-
2:46
dr. brufsky on the fda approval of olaparib in brca breast cancer
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
1:07
dr. brufsky on challenges facing biosimilars in breast cancer
-
1:38
dr. brufsky on the results of a study of trastuzumab and eribulin for her2 mbc
-
6:41
practice-changing results from the mindact trial
-
3:40
treatment with eribulin in metastatic breast cancer
-
1:41
dr. brufsky on implementing pertuzumab in her2 breast cancer